Literature DB >> 27761885

Diagnostic assessment of intraoperative cytology for papillary thyroid carcinoma: using a decision tree analysis.

J-S Pyo1, J H Sohn2, G Kang3.   

Abstract

PURPOSE: The aim of this study was to elucidate the cytological characteristics and the diagnostic usefulness of intraoperative cytology (IOC) for papillary thyroid carcinoma (PTC). In addition, using decision tree analysis, effective features for accurate cytological diagnosis were sought.
METHODS: We investigated cellularity, cytological features and diagnosis based on the Bethesda System for Reporting Thyroid Cytopathology in IOC of 240 conventional PTCs. The cytological features were evaluated in terms of nuclear score with nuclear features, and additional figures such as presence of swirling sheets, psammoma bodies, and multinucleated giant cells. The nuclear score (range 0-7) was made via seven nuclear features, including (1) enlarged, (2) oval or irregularly shaped nuclei, (3) longitudinal nuclear grooves, (4) intranuclear cytoplasmic pseudoinclusion, (5) pale nuclei with powdery chromatin, (6) nuclear membrane thickening, and (7) marginally placed micronucleoli.
RESULTS: Nuclear scores in PTC, suspicious for malignancy, and atypia of undetermined significance cases were 6.18 ± 0.80, 4.48 ± 0.82, and 3.15 ± 0.67, respectively. Additional figures more frequent in PTC than in other diagnostic categories were identified. Cellularity of IOC significantly correlated with tumor size, nuclear score, and presence of additional figures. Also, IOCs with higher nuclear scores (4-7) significantly correlated with larger tumor size and presence of additional figures. In decision tree analysis, IOCs with nuclear score >5 and swirling sheets could be considered diagnostic for PTCs.
CONCLUSIONS: Our study suggests that IOCs using nuclear features and additional figures could be useful with decreasing the likelihood of inconclusive results.

Entities:  

Keywords:  Decision tree analysis; Fine-needle aspiration; Intraoperative cytology; Papillary thyroid carcinoma; Thyroid nodule

Mesh:

Year:  2016        PMID: 27761885     DOI: 10.1007/s40618-016-0563-0

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  18 in total

1.  American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations.

Authors:  H Gharib; E Papini; R Paschke; D S Duick; R Valcavi; L Hegedüs; P Vitti
Journal:  J Endocrinol Invest       Date:  2010       Impact factor: 4.256

2.  Core-needle biopsy is more useful than repeat fine-needle aspiration in thyroid nodules read as nondiagnostic or atypia of undetermined significance by the Bethesda system for reporting thyroid cytopathology.

Authors:  Dong Gyu Na; Ji-hoon Kim; Jin Yong Sung; Jung Hwan Baek; Kyeong Cheon Jung; Hunkyung Lee; Hyunju Yoo
Journal:  Thyroid       Date:  2012-02-03       Impact factor: 6.568

3.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

4.  The Bethesda System for Reporting Thyroid Cytopathology.

Authors:  Edmund S Cibas; Syed Z Ali
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

5.  BRAF mutation analysis in thyroid nodules with indeterminate cytology: our experience on surgical management of patients with thyroid nodules from an area of borderline iodine deficiency.

Authors:  P Agretti; F Niccolai; T Rago; G De Marco; A Molinaro; M Scutari; C Di Cosmo; G Di Coscio; M Vitale; M Maccheroni; P Vitti; M Tonacchera
Journal:  J Endocrinol Invest       Date:  2014-09-07       Impact factor: 4.256

6.  Activation of nuclear factor-κB contributes to growth and aggressiveness of papillary thyroid carcinoma.

Authors:  Jung-Soo Pyo; Guhyun Kang; Dong Hoon Kim; Seoung Wan Chae; Chanheun Park; Kyungeun Kim; Sung-Im Do; Hyun Joo Lee; Joo Heon Kim; Jin Hee Sohn
Journal:  Pathol Res Pract       Date:  2013-03-05       Impact factor: 3.250

7.  The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference.

Authors:  Ritu Nayar; Marina Ivanovic
Journal:  Cancer       Date:  2009-06-25       Impact factor: 6.860

8.  Thyroid nodules with initially non-diagnostic, fine-needle aspiration results: comparison of core-needle biopsy and repeated fine-needle aspiration.

Authors:  Sang Hyun Choi; Jung Hwan Baek; Jeong Hyun Lee; Young Jun Choi; Min Ji Hong; Dong Eun Song; Jae Kyun Kim; Jong Ho Yoon; Won Bae Kim
Journal:  Eur Radiol       Date:  2014-07-20       Impact factor: 5.315

9.  Touch imprint and crash preparation intra operative cytology versus frozen section in thyroid nodule.

Authors:  Ali Chehrei; Mojtaba Ahmadinejad; Sayyed Abbas Tabatabaee; Sayyed Mozaffar Hashemi; Mahsa Kianinia; Shahin Fateh; Mohammad Hossein Sanei
Journal:  J Res Med Sci       Date:  2012-05       Impact factor: 1.852

10.  Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: a 2015 position statement of the Italian Society of Endocrinology.

Authors:  F Pacini; E Brianzoni; C Durante; R Elisei; M Ferdeghini; L Fugazzola; S Mariotti; G Pellegriti
Journal:  J Endocrinol Invest       Date:  2015-08-12       Impact factor: 4.256

View more
  1 in total

1.  Using k-dependence causal forest to mine the most significant dependency relationships among clinical variables for thyroid disease diagnosis.

Authors:  LiMin Wang; FangYuan Cao; ShuangCheng Wang; MingHui Sun; LiYan Dong
Journal:  PLoS One       Date:  2017-08-17       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.